Prokaryotic expression, purification and identification of recombinant human atrial natriuretic peptide.
- Author:
Chenhui CHEN
1
;
Ziye ZHAO
2
;
Jin XU
3
;
Xuesong CAO
2
;
Shangjing GUO
4
;
Jun LI
4
;
Hao WANG
5
;
Sheng HOU
5
Author Information
- Publication Type:Journal Article
- Keywords: atrial natriuretic peptide; peptides purification; tandem expression
- MeSH: Atrial Natriuretic Factor; biosynthesis; Electrophoresis, Polyacrylamide Gel; Escherichia coli; metabolism; Gene Expression; Humans; Metalloendopeptidases; Peptides; Plasmids; genetics; Recombinant Fusion Proteins; biosynthesis
- From: Chinese Journal of Biotechnology 2016;32(9):1273-1285
- CountryChina
- Language:Chinese
- Abstract: In order to improve the expression of recombinant human atrial natriuretic peptide (ANP), a new plasmid (pET28a(+)/ANP₃) containing 3 tandem ANP genes with lysine codon as the interval linker, was constructed. Target gene was transformed into Escherichia coli BL21 (DE3) and induced by IPTG, about 60% of the total-cell-protein was the target protein, His₆-ANP₃. After denaturation and refolding, it was digested by Endoproteinase Lys-C and Carboxypeptidase B (CPB) and then purified by a series of purification processes, about 16 mg purified ANP monomer could be obtained from one liter bacteria broth of shaking culture. Ultimately, the purity of protein was above 90% determined by UPLC and Tricine SDS-PAGE, its molecular weight was 3 080 Da according to LC-MS identification and it was proved to be equivalent to the reference product by ELISA. The use of tandem gene expression can provide a new possible model for the expression of other peptide drugs.